Company intelligence / Profile preview

IonSpec

Lake Forest, California, USA

Ownership: Private
Development stage: Other

Overview

IonSpec Corporation was a pioneering life science instrumentation company that specialized in Fourier Transform Mass Spectrometry (FTMS) technology. Established in 1983, the company developed high-performance mass spectrometers that offered unparalleled resolution and mass accuracy for the analysis of large biomolecules. These systems were critical for applications in proteomics, drug discovery, and metabolomics within the pharmaceutical industry. In February 2002, IonSpec was acquired by Varian, Inc. for approximately $12 million to bolster Varian's analytical instrument offerings. Following Agilent Technologies' acquisition of Varian in 2010, IonSpec's core technologies were integrated into Agilent's broader mass spectrometry portfolio.

Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on IonSpec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IonSpec.

Explore the full profile